Cargando…
Is retinal vasculature a biomarker in amyloid proven Alzheimer's disease?
INTRODUCTION: The retina is a potential source of noninvasive vascular biomarkers for Alzheimer's disease (AD). We assessed retinal microvasculature in well-characterized AD cases, taking ophthalmological confounders into account. METHODS: We included 48 amyloid-positive AD patients and 38 amyl...
Autores principales: | den Haan, Jurre, van de Kreeke, Jacoba A., van Berckel, Bart N., Barkhof, Frederik, Teunissen, Charlotte E., Scheltens, Philip, Verbraak, Frank D., Bouwman, Femke H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6517376/ https://www.ncbi.nlm.nih.gov/pubmed/31193094 http://dx.doi.org/10.1016/j.dadm.2019.03.006 |
Ejemplares similares
-
Retinal thickness as a potential biomarker in patients with amyloid-proven early- and late-onset Alzheimer's disease
por: den Haan, Jurre, et al.
Publicado: (2019) -
Retinal thickness correlates with parietal cortical atrophy in early-onset Alzheimer's disease and controls
por: den Haan, Jurre, et al.
Publicado: (2017) -
Retinal thickness in Alzheimer's disease: A systematic review and meta-analysis
por: den Haan, Jurre, et al.
Publicado: (2017) -
No difference in retinal fluorescence after oral curcumin intake in amyloid‐proven AD cases compared to controls
por: den Haan, Jurre, et al.
Publicado: (2022) -
Feasibility study for detection of retinal amyloid in clinical trials: The Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial
por: Ngolab, Jennifer, et al.
Publicado: (2021)